Antimicrobial peptides (AMPs) are a broad classification assigned to many gene products that have the ability to kill or inhibit the growth of microbes. Cathelicidins are a major family of AMPs that are expressed in vertebrates to provide defense against infection, and inactivated by pathogens as a mechanism to enhance virulence. Although the cathelicidin gene is evolutionarily conserved within vertebrates, the sequence of exon 4 of the cathelicidin gene has diverged significantly between species. This exon encodes the carboxy-terminus of the precursor protein that is post-translationally processed into the final mature AMP. The structure of this mature peptide is critical for function within the specific defense context. For example, the human cathelicidin gene CAMP if expressed as the mature peptide LL37 has potent pro-inflammatory activity in addition to its capacity to kill microbes. This provides enhanced host defense during infection when such expression is appropriate, but promotes several human skin diseases where inappropriate expression occurs. Because cathelicidin appears to drive human inflammatory diseases such as rosacea and psoriasis, it is important to understand the mechanism of action of this unique AMP. The basis of this renewal proposal are exciting new preliminary data that have provided a breakthrough in understanding how LL37 mediates inflammation. Findings suggest that LL37 mediates receptor-dependent recognition of nucleic acids. We have termed this process ?innate immune vetting? since we hypothesize that LL37 dictates if nucleic acids will induce an inflammatory response. The overall goal of this renewal application is to better understand the mechanism by which LL37 triggers inflammation and explore potential strategies that will modify this event and treat disease.
Cathelicidin is a type of antimicrobial peptide known to be important to human disease since infection occurs when expression of this peptide is insufficient, and inflammation occurs when cathelicidin is too abundant. This project builds on a breakthrough discovery into the mechanism of action of cathelicidin to promote inflammation. Our approach seeks to better understand this process and explore potential strategies that can be exploited to treat disease.
|Kumaraswamy, Monika; Do, Carter; Sakoulas, George et al. (2018) Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents 51:468-478|
|Dokoshi, Tatsuya; Zhang, Ling-Juan; Nakatsuji, Teruaki et al. (2018) Hyaluronidase inhibits reactive adipogenesis and inflammation of colon and skin. JCI Insight 3:|
|Sato, Emi; Williams, Michael R; Sanford, James A et al. (2017) The parathyroid hormone family member TIP39 interacts with sarco/endoplasmic reticulum Ca2+ - ATPase activity by influencing calcium homoeostasis. Exp Dermatol 26:792-797|
|Lee, Ernest Y; Takahashi, Toshiya; Curk, Tine et al. (2017) Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation. ACS Nano 11:12145-12155|
|Sakoulas, George; Rose, Warren; Berti, Andrew et al. (2017) Classical ?-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii. Antimicrob Agents Chemother 61:|
|Williams, Michael R; Nakatsuji, Teruaki; Sanford, James A et al. (2017) Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes. J Invest Dermatol 137:377-384|
|Kulkarni, Nikhil N; Adase, Christopher A; Zhang, Ling-Juan et al. (2017) IL-1 Receptor-Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation. J Invest Dermatol 137:2417-2426|
|Valderrama, J Andrés; Riestra, Angelica M; Gao, Nina J et al. (2017) Group A streptococcal M protein activates the NLRP3 inflammasome. Nat Microbiol 2:1425-1434|
|Munguia, Jason; LaRock, Doris L; Tsunemoto, Hannah et al. (2017) The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance. J Mol Med (Berl) 95:1127-1136|
|Nakatsuji, Teruaki; Chen, Tiffany H; Narala, Saisindhu et al. (2017) Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med 9:|
Showing the most recent 10 out of 157 publications